Goff Brian
Insider CIK 1546216 · AGIO Chief Executive Officer, Director · BXLT EVP and President, Hematology · NTLA Director · ALXN EVP & Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-18 | 2026-06-23 | 39,000 | — | $0 | 39,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 39,000 | — | $0 | 39,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 13,300 | — | $0 | 13,300 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-06-09 | 2026-06-10 | 9,200 | — | $0 | 32,609 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-04-02 | 2026-04-06 | 25,528 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-04-02 | 2026-04-06 | 13,500 | — | $0 | 40,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-04-02 | 2026-04-06 | 13,500 | — | $0 | 191,104 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-04-02 | 2026-04-06 | 25,528 | — | $0 | 190,076 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2026-04-02 | 2026-04-06 | 6,596 | $34.71 | $228.9K | 184,508 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2026-04-02 | 2026-04-06 | 12,472 | $34.71 | $432.9K | 177,604 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-03-02 | 2026-03-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-03-02 | 2026-03-03 | 8,500 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-03-02 | 2026-03-03 | 13,000 | — | $0 | 26,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-03-02 | 2026-03-03 | 13,000 | — | $0 | 170,466 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2026-03-02 | 2026-03-03 | 8,267 | $28.96 | $239.4K | 157,466 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-03-02 | 2026-03-03 | 18,000 | — | $0 | 165,733 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2026-03-02 | 2026-03-03 | 3,870 | $28.96 | $112.1K | 147,733 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-03-02 | 2026-03-03 | 8,500 | — | $0 | 151,603 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2026-03-02 | 2026-03-03 | 5,918 | $28.96 | $171.4K | 164,548 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-03-01 | 2026-03-03 | 174,000 | — | $0 | 174,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-03-01 | 2026-03-03 | 48,000 | — | $0 | 48,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-12-30 | 2026-01-02 | 25,528 | — | $0 | 25,528 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-12-30 | 2026-01-02 | 12,750 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-12-30 | 2026-01-02 | 6,230 | $27.09 | $168.8K | 143,103 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-12-30 | 2026-01-02 | 25,528 | — | $0 | 149,056 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-12-30 | 2026-01-02 | 12,473 | $27.09 | $337.9K | 136,583 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-12-30 | 2026-01-02 | 12,750 | — | $0 | 149,333 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-08-08 | 2025-08-12 | 22,691 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-08-08 | 2025-08-12 | 11,085 | $36.67 | $406.5K | 123,528 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-08-08 | 2025-08-12 | 22,691 | — | $0 | 134,613 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-24 | 2025-06-26 | 12,750 | — | $0 | 12,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-24 | 2025-06-26 | 25,527 | — | $0 | 51,056 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-24 | 2025-06-26 | 25,527 | — | $0 | 117,872 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-06-24 | 2025-06-26 | 6,229 | $33.54 | $208.9K | 111,922 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-06-24 | 2025-06-26 | 12,471 | $33.54 | $418.3K | 105,401 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-24 | 2025-06-26 | 12,750 | — | $0 | 118,151 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 11,450 | — | $0 | 11,450 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-06-11 | 2025-06-13 | 8,000 | — | $0 | 23,409 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-03-03 | 2025-03-04 | 8,794 | $35.54 | $312.5K | 92,345 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2025-03-03 | 2025-03-04 | 4,153 | $35.54 | $147.6K | 83,139 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-03-01 | 2025-03-04 | 142,500 | — | $0 | 142,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-03-01 | 2025-03-04 | 39,000 | — | $0 | 39,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-03-01 | 2025-03-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-03-01 | 2025-03-04 | 18,000 | — | $0 | 36,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-03-01 | 2025-03-04 | 8,500 | — | $0 | 87,292 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-03-01 | 2025-03-04 | 18,000 | — | $0 | 101,139 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-08-08 | 2024-08-12 | 22,691 | — | $0 | 22,691 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-08-08 | 2024-08-12 | 11,091 | $42.75 | $474.1K | 78,792 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-08-08 | 2024-08-12 | 22,691 | — | $0 | 89,883 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-06-13 | 2024-06-17 | 22,297 | — | $0 | 22,297 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-06-13 | 2024-06-17 | 15,409 | — | $0 | 15,409 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-06-05 | 2024-06-07 | 25,527 | — | $0 | 76,583 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-06-05 | 2024-06-07 | 25,527 | — | $0 | 79,307 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-06-05 | 2024-06-07 | 12,115 | $48.84 | $591.7K | 67,192 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-03-05 | 2024-03-05 | 4,156 | $32.57 | $135.4K | 53,780 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-03-01 | 2024-03-05 | 195,500 | — | $0 | 195,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-03-01 | 2024-03-05 | 54,000 | — | $0 | 54,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-03-01 | 2024-03-05 | 8,500 | — | $0 | 17,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-03-01 | 2024-03-05 | 8,500 | — | $0 | 57,936 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-01-24 | 2024-01-24 | 7,635 | $21.64 | $165.2K | 49,436 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-01-20 | 2024-01-24 | 17,018 | — | $0 | 102,110 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-01-20 | 2024-01-24 | 17,018 | — | $0 | 57,071 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2024-01-09 | 2024-01-09 | 12,066 | $22.99 | $277.4K | 40,053 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-01-05 | 2024-01-09 | 25,527 | — | $0 | 119,128 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-01-05 | 2024-01-09 | 25,527 | — | $0 | 52,119 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-08-08 | 2023-08-10 | 22,691 | — | $0 | 45,382 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-08-08 | 2023-08-10 | 22,691 | — | $0 | 36,770 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2023-08-08 | 2023-08-10 | 10,178 | $25.48 | $259.3K | 26,592 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | S Sale | 2023-06-30 | 2023-06-30 | 11,449 | $28.36 | $324.7K | 14,079 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-06-28 | 2023-06-30 | 25,528 | — | $0 | 144,655 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-06-28 | 2023-06-30 | 25,528 | — | $0 | 25,528 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-03-01 | 2023-03-03 | 94,500 | — | $0 | 94,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-03-01 | 2023-03-03 | 25,500 | — | $0 | 25,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-08-08 | 2022-08-09 | 561,083 | — | $0 | 561,083 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-08-08 | 2022-08-09 | 68,073 | — | $0 | 68,073 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer deriv | 2021-07-21 | 2021-07-23 | 21,750 | $100.14 | $2.18M | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer | 2021-07-21 | 2021-07-23 | 150,832 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-07-14 | 2021-07-16 | 29,501 | — | $0 | 150,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-07-14 | 2021-07-16 | 30,643 | — | $0 | 121,331 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2021-06-08 | 2021-06-09 | 1,086 | $177.00 | $192.2K | 90,688 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-02-28 | 2021-03-02 | 24,473 | — | $0 | 91,774 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-12-16 | 2020-12-18 | 3,261 | $157.96 | $515.1K | 67,301 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-12-16 | 2020-12-18 | 18,134 | $157.96 | $2.86M | 70,562 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-12-16 | 2020-12-18 | 40,677 | — | $0 | 88,696 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-06-08 | 2020-06-09 | 1,642 | $114.61 | $188.2K | 48,019 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-03-02 | 2020-03-03 | 1,401 | $90.54 | $126.8K | 49,661 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-02-28 | 2020-03-03 | 10,880 | — | $0 | 51,062 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-02-07 | 2020-02-10 | 1,594 | $102.97 | $164.1K | 40,182 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-06-07 | 2019-06-11 | 1,643 | $118.61 | $194.9K | 41,776 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-04 | 670 | $132.93 | $89.1K | 33,991 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-02-28 | 2019-03-05 | 9,428 | — | $0 | 43,419 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-07 | 2019-02-11 | 1,596 | $119.57 | $190.8K | 34,661 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-06-08 | 2018-06-12 | 1,645 | $118.53 | $195.0K | 36,257 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-28 | 2018-03-02 | 8,940 | — | $0 | 37,902 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-08 | 2018-02-08 | 1,651 | $116.31 | $192.0K | 28,962 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-06 | 2018-02-08 | 15,894 | — | $0 | 30,613 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2017-06-07 | 2017-06-09 | 21,750 | $100.14 | $2.18M | 21,750 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-06-07 | 2017-06-09 | 14,719 | — | $0 | 14,719 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 265,221 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 35,170 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 88,168 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 31,376 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 25,773 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer deriv | 2016-06-03 | 2016-06-07 | 37,000 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | D To issuer | 2016-06-03 | 2016-06-07 | 70,047 | — | $0 | 0 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-06-03 | 2016-06-07 | 2,881 | — | $0 | 70,047 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2016-03-07 | 2016-03-08 | 267 | $39.74 | $10.6K | 67,030 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2016-03-04 | 2016-03-07 | 303 | $39.47 | $12.0K | 67,297 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2016-03-03 | 2016-03-07 | 1,338 | $39.30 | $52.6K | 67,600 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-03-03 | 2016-03-07 | 35,605 | — | $0 | 68,938 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-02-15 | 2016-02-17 | 508 | — | $0 | 33,335 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2016-02-15 | 2016-02-17 | 552 | — | $0 | 33,360 | SEC↗ |
| BXLT Baxalta Inc | F Tax w/h | 2016-02-15 | 2016-02-17 | 533 | $39.00 | $20.8K | 32,827 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2015-08-11 | 2015-08-13 | 157 | — | $0 | 32,600 | SEC↗ |
| BXLT Baxalta Inc | A Award | 2015-08-11 | 2015-08-13 | 135 | — | $0 | 32,443 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 31,376 | — | $0 | 31,376 | SEC↗ |
| BXLT Baxalta Inc | A Award deriv | 2015-07-01 | 2015-07-06 | 265,221 | — | $0 | 265,221 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 37,000 | — | $0 | 37,000 | SEC↗ |
| BXLT Baxalta Inc | A Award deriv | 2015-07-01 | 2015-07-06 | 35,170 | — | $0 | 35,170 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 88,168 | — | $0 | 88,168 | SEC↗ |
| BXLT Baxalta Inc | J Other deriv | 2015-07-01 | 2015-07-06 | 25,773 | — | $0 | 25,773 | SEC↗ |
| BXLT Baxalta Inc | J Other | 2015-07-01 | 2015-07-06 | 28,154 | — | $0 | 32,308 | SEC↗ |
| BXLT Baxalta Inc | J Other | 2015-07-01 | 2015-07-06 | 4,154 | — | $0 | 4,154 | SEC↗ |